| Literature DB >> 30067600 |
Athena P Kourtis1, Jeffrey Wiener1, Liming Wang2, Bo Fan3, John A Shepherd3, Lili Chen4, Wei Liu5, Colin Shepard2, Linhong Wang6, Ailin Wang6, Marc Bulterys2.
Abstract
The effects of maternal tenofovir use on infant bone mineral content (BMC) and bone mineral density (BMD) were evaluated in a pilot study of HIV/Hepatitis B-coinfected pregnant women in China. BMD and BMC were assessed at age 6 months of life in 14 tenofovir-exposed and 13 unexposed infants. Trends toward lower BMC and BMD were observed in infants exposed to maternal tenofovir but were not statistically significant.Entities:
Mesh：
Substances：
Year: 2018 PMID： 30067600 DOI： 10.1097/INF.0000000000002152
Source DB: PubMed Journal: Pediatr Infect Dis J ISSN： 0891-3668 Impact factor: 2.129